Patient-derived xenograft: a developing tool for screening biomarkers and potential therapeutic targets for human esophageal cancers (2021)

First Author: Lan Tianfeng

Attributed to: Development of an effective therapeutic regime for preventing cancer recurrence after surgery using a novel viro-immunotherapeutic agent funded by MRC

No abstract provided

Type: Journal Article/Review

Volume: 13

Parent Publication: AGING-US

Issue: 8

ISSN: 1945-4589